Leaflet RINOGUT 0.1% nasal drops, solution
Indicated for: nasal or conjunctival congestion
Route of administration: nasal
Substance: naphazoline (adrenergic decongestant)
ATC: R01AA08 (Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, plain)
This medicine may cause dizziness or vertigo.
Use caution if you have glaucoma or increased eye pressure.
This medicine may increase the risk of heart rhythm disturbances.
Naphazoline is a nasal decongestant used to relieve nasal congestion associated with colds, sinusitis, or allergic rhinitis. It works by constricting blood vessels in the nasal mucosa, reducing inflammation and congestion.
The medication is available as nasal drops or spray and provides rapid symptom relief. However, long-term use may lead to adverse effects such as rebound congestion (rhinitis medicamentosa).
Side effects may include dryness of the nasal mucosa, burning sensation, or local irritation. It is important not to exceed the recommended duration of use, typically 3-5 days.
Consult your doctor before use, especially if you have cardiovascular conditions, high blood pressure, or other health issues. Use Naphazoline as directed to avoid complications.
General data about RINOGUT 0.1%
- Substance: naphazoline
- Date of latest medicines list: 01-07-2013
- Product code: W43010001
- Concentration: 0.1%
- Pharmaceutical form: nasal drops, solution
- Quantity: 1
- Product type: Generic medicine
- Prescription status: OTC - Over the Counter = medicine that does not require a medical prescription.
Pharmaceutical forms available for naphazoline
Concentrations available for naphazoline
- 0.0125
- 0.03%
- 0.05%
- 0.1%
- 0.3mg/ml